This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Americas COVID-19 Testing Market

Market Insights on Americas COVID-19 Testing covering sales outlook, demand forecast & up-to-date key trends

Americas COVID-19 Testing Market by Test Type (SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits, SARS-CoV-2 Antigen Rapid Test Kits, Multiplex Real-Time RT-PCR Assay Kits), Sample Type (Blood, Nasopharyngeal Swabs), Distribution Channel & Region - Forecast to 2021-2031

Americas COVID-19 Testing Market Snapshot

The Americas COVID-19 testing market revenue totaled US$ 4,508 Mn for 2021, finds Future Market Insights (FMI) in a new study. The overall COVID-19 testing market size in the Americas is expected to surpass US$ 7,264.4 Mn by 2031. FMI projects the demand in the market to rise at a CAGR of 4.9% for 2021 - 2031.

Unprecedented COVID-19 outbreak, its rapid spread on a global scale, and the relatively high risk of morbidity and mortality have caused the demand for COVID-19 testing to skyrocket. Demand for sampling kits with nasopharyngeal swabs will rise at a high pace, accounting for over 86% of sales in Americas in 2021.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered in Americas COVID-19 Testing Market Study

  • Market estimates and forecast 2016-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Americas COVID-19 Testing Market and How to Navigate
  • Recommendation on Key Winning Strategies

Americas COVID-19 Testing Market Forecast Outlook 2021-2031 in Comparison to Sales Registered in 2016-2020

According to Future Market Insights (FMI), the sales of COVID-19 testing kits in the Americas are expected to grow at almost 5% CAGR between 2021 and 2031. The SARS-Cov-2 virus is highly infectious and can spread at a very high rate. It can cause health concerns such as mild fever, cough, cold, and body aches. If left unchecked it might even prove fatal.

To detect the virus early and to reduce its spread, it is important to diagnose the presence of infection in human body. Early detection aids timely treatment that can help controlling symptoms and offering better patient care. Nasopharyngeal swab samples are most commonly used due to high availability and convenience.

Americas COVID-19 Testing Market Download Report Brochure

The report presents insights into key market players and strategies they adopt to gain competitive edge. There is high focus on collaborations among market players as they aim for expanding COVID-19 testing product portfolios.

For instance, in March 2020, Biolidics Limited, a medical technology company known for developing advanced diagnostic solutions acquired Biomedics Laboratory to boost its commercialization capabilities and to bolster its revenue model.

In June 2021, SD BIOSENSOR, gained the CE certification for its product 'SARS-CoV-2 Antigen Self-Test Nasal'. The developmental stages of advanced Americas COVID-19 testing require significant capital. With the rise in the number of new entrants, overall research and development expenses are projected to rise exponentially, with collaborations and licensing agreements for research institutes.

With healthcare spending consistently rising in developed countries, the demand for COVID-19 testing in the Americas is expected to rise over the coming decade.

How will Increasing Focus on Vaccination Affect COVID-19 Testing Kits Sales?

With the focus gradually shifting on vaccination, the interest in testing products is expected to wane in the near future. However, in the long run COVID-19 testing is expected to become a common practice for diagnosis of patients who have flu like symptoms.

E-commerce is gaining popularity in the last few years owing to the prominence of the internet. Also, the COVID-19 pandemic is creating a scenario where online sales are preferred due to social distancing rules. As a result, online availability of COVID-19 self-testing kits is expected to  surge, in turn creating  lucrative prospects for growth in the Americas.

What Factors will Restrain COVID-19 Testing in the Americas?

Risk of diagnostic errors is a critical factor that is restraining the market . COVID-19 is a novel disease and knowledge about this disease is very limited. This increases the risks of error in the diagnostic systems. False positives or negatives can lead to various problems and complications in the treatment process.

With the launch of vaccines, the pandemic situation is expected to gradually subside, thereby reducing the number of tests required.  Such obstacles would have a direct impact on the overall user convenience of COVID-19 testing in the Americas, thereby limiting revenue generation options.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

How is the COVID-19 Testing Market Faring in the U.S.?

The U.S. will hold nearly 70% share of the Americas COVID-19 testing market in 2021. In the U.S., the market is led by research collaborations and license agreement for healthcare products. Recent technological advancements will create opportunities for development of innovative products.

Key players are currently focusing on strategies including acquisitions and mergers in addition to new product launches in the region. For instance, in June 2020, the Novacyt Group announced the launch of three products for Americas COVID-19 testing. The products are Exsig™ Direct, Exsig™ Mag i.e. RNA extraction kits and COVID-HT test i.e. a high-throughput test for COVID-19. These products are going to support the COVID-19 diagnosis segment of the company.

What Factors are Driving Growth in Canada?

The Canada market will exhibit 4.8% CAGR through the assessment period. Rising prevalence of COVID-19 infections and technological advancements in the healthcare sector are key factors are projected to help the Canada market for COVID-19 testing gain momentum in the coming years. Besides this, favorable reimbursement policies will continue creating opportunities for growth.

What Opportunities will Manufacturers Capitalize on for Growth in Brazil?

Brazil accounts for over 50% of the Latin America market through the forecast period. Key players of the country are largely focusing on expanding their market presence in the Americas. Steps taken by government in Brazil to contain the virus have been a key growth enabler.

Following the announcement by the World Health Organization (WHO), declaring the novel coronavirus outbreak a public health emergency, Brazil actively readied for the pandemic. The Ministry of Health in the country established an Emergency Operations Centre (COE) to prepare the healthcare system to actively respond to the medical emergency.

Substantial progress in actions taken to contain the unprecedented outbreak created attractive prospects for COVID-19 testing market in the country.

Category-wise Insights

How are SARS-CoV-2 Antigen Rapid Test Kits Contributing to Revenue Generation?

SARS-CoV-2 antigen rapid test kits have a higher potential for growth in the coming years. The segment is likely to display a relatively high CAGR of 4.8% in the near future and with revenue totalling US$ 2,903.0 Mn in 2020. Preference for rapid testing kits promotes the growth of this segment in the long term.

What is the Market Share of Nasopharyngeal Swabs?

Nasopharyngeal swabs will continue to dominate the market during the forecast period and are expected to hold around 87% of the market share at the end of 2031. This can be largely be attributed to benefits including low costs, ease of application, and minimal discomfort to the patient.

What is the Scope of Growth for Online Sales Channels?

Despite hospital pharmacies currently leading the market, online sales channels are expected to experience significant growth in the Americas COVID-19 testing  markets with a 6.8% CAGR for the duration of the forecast period. This can be primarily attributed to higher acceptance of online sales, and convenience to users along with discounts and offers making reducing costs through home deliveries.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

Manufacturers in the Americas COVID-19 testing market are primarily aiming at strategic acquisitions, collaborations, and launches of innovative products to cater to market demand. Production capacity expansion is also likely to gain traction as global demand for testing continues rising at a rapid rate.

  • For instance, Sugentech, Inc. begun the distribution of SGTi-flex COVID-19 IgM/IgG test kit after gaining FDA approval in April, 2020.
  • In August 2020, Novacyt Group launched Winterplex™ which is a CE-Mark approved polymerase chain reaction (PCR) respiratory test panel.
  • In May 2020, Biomerieux SA announced the launch of the VIDAS anti-SARS-CoV-2 serology tests which detects the presence of antibodies in the body for SARS-COV-2. The product has received a CE mark.

Scope of the Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2020

Market Analysis

USD Million for Value/ Units for Volume

Key Regions Covered

North America, Latin America

Key Countries Covered

US, Canada, Germany, Brazil, Mexico, Argentina, and Chile

Key Segments Covered

Test Type, Sample Type, Distribution Channel, and Region

Key Companies Profiled

  • Sky Medical Supplies & Equipment LLC.
  • Sugentech, Inc.
  • Novacyt Group
  • Aurora Instruments Ltd.
  • PRIMA Lab SA
  • SD Biosensor, INC.
  • Gold Standard Diagnostics
  • Eurofins Technologies
  • Biomerieux SA
  • Danaher

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Americas COVID-19 testing Market by Category

Test Type:

  • SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits
  • SARS-CoV-2 Antigen Rapid Test Kits
  • Multiplex Real-Time RT-PCR Assay Kits

Sample Type:

  • Blood
  • Nasopharyngeal Swabs

Distribution Channel:

  • Hospital Pharmacies
  • Diagnostic Laboratories
  • Retail Pharmacies
  • Drug Store
  • Online Sales Channels

Region:

  • North America
  • Latin America

Frequently Asked Questions

As per Future Market Insights’, revenue generated from the Americas COVID-19 testing market is estimated to be valued at US$ 4508 Mn in 2021.

The market is expected to reach value of US$ 7264 Mn by the end of 2031 with sales revenue expected to increase at a CAGR of 4.9% over the forecast period.

The demand for COVID-19 testing will continue increasing on account of the rise in point-of-care testing settings, increasing awareness in general population, and support from government bodies.

The U.S. is driving the demand for COVID-19 testing in the Americas. This is primarily due to the large number of test kits being approved by the FDA during the pandemic.

North America is the dominant region for COVID-19 testing production and sales. According to Future Market Insights, the U.S. is expected to account for over 70% of the North America and Latin America market by the end of the forecast period.

Demand in the COVID-19 testing market is anticipated to register growth rate of 1.9% in Latin America during the forecast period.

Sky Medical Supplies & Equipment LLC., Sugentech, Inc., Novacyt Group, Aurora Instruments Ltd., PRIMA Lab SA, SD Biosensor, INC., Gold Standard Diagnostics, Eurofins Technologies, Biomerieux SA, and Danaher are the key expoters of COVID 19 testing kits.

The sales of COVID-19 testing in Brazil and Mexico are expected to rise at a CAGR of 2.8% and 1.7% respectively throughout the forecast period.

Table of Content

1. Executive Summary

    1.1. America’s Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. GDP Growth Outlook

        4.1.2. America’s Healthcare Industry Outlook

        4.1.3. America’s Pharmaceutical Market Expenditure

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity Analysis

5. America’s Covid-19 testing Market Volume (Units) Analysis Forecast, 2021-2031

    5.1. Historical Market Volume (Units) Analysis, 2016-2020

    5.2. Current and Future Market Volume (Units) Projections, 2021-2031

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. America’s Covid-19 testing Market - Pricing Analysis

    6.1. Country Pricing Analysis by Test Type

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Latin America and Middle East Average Pricing Analysis Benchmark

7. America’s Covid-19 testing Market Value Analysis Forecast, 2021-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. America’s Covid-19 testing Market Analysis Forecast 2021-2031, by Test Type 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis by Product Type, 2016-2020

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product Type, 2021-2031

        8.3.1. SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits

        8.3.2. SARS-CoV-2 Antigen Rapid Test Kits

        8.3.3. Multiplex Real-Time RT-PCR Assay Kits

    8.4. Market Attractiveness Analysis by Test Type

9. America’s Covid-19 testing Market Analysis Forecast 2021-2031, by Sample Type 

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis by Sample Type, 2016-2020

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Sample Type, 2021-2031

        9.3.1. Blood

        9.3.2. Nasopharyngeal Swabs

    9.4. Market Attractiveness Analysis by Sample Type

10. America’s Covid-19 testing Market Analysis Forecast 2021-2031, By Distribution Channel 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021-2031

        10.3.1. Hospital Pharmacies

        10.3.2. Diagnostic Laboratories

        10.3.3. Retail Pharmacies

        10.3.4. Drug Store

        10.3.5. Online Sales Channels 

    10.4. Market Attractiveness Analysis by Distribution Channel

11. America’s Covid-19 testing Market Analysis Forecast 2021-2031, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

        11.3.1. North America

        11.3.2. Latin America

    11.4. Market Attractiveness Analysis By Region

12. U.S. Covid-19 testing Market Analysis Forecast 2021-2031

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        12.3.1.  By Test Type

        12.3.2. By Sample Type

        12.3.3. By Distribution Channel

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Canada Covid-19 testing Market Analysis Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        13.3.1.  By Test Type

        13.3.2. By Sample Type

        13.3.3. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Covid-19 testing Market Analysis Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        14.3.1.  By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

        14.3.2. By Test Type

        14.3.3. By Sample Type

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Market Structure Analysis

    15.1. Market Analysis by Tier of Companies

    15.2. Market Concentration

    15.3. Market Share Analysis of Top Players

    15.4. Market Presence Analysis

        15.4.1. By Regional Foot Print of Players

        15.4.2. Product Foot Print by Players

        15.4.3. Channel Foot Print by Players

16. Competition Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Competition Deep Dive 

        16.3.1. Biolidics Limited

            16.3.1.1. Overview

            16.3.1.2. Product Portfolio

            16.3.1.3. Analyst Commentary 

            16.3.1.4. Key Financials

            16.3.1.5. Recent Developments

            16.3.1.6. Sales Footprint

            16.3.1.7. Strategy Overview

                16.3.1.7.1. Marketing Strategy

                16.3.1.7.2. Product Strategy

                16.3.1.7.3. Channel Strategy

        16.3.2. Sky Medical Supplies & Equipment LLC

            16.3.2.1. Overview

            16.3.2.2. Product Portfolio

            16.3.2.3. Analyst Commentary 

            16.3.2.4. Key Financials

            16.3.2.5. Recent Developments

            16.3.2.6. Sales Footprint

            16.3.2.7. Strategy Overview

                16.3.2.7.1. Marketing Strategy

                16.3.2.7.2. Product Strategy

                16.3.2.7.3. Channel Strategy

        16.3.3. Sugentech, Inc.

            16.3.3.1. Overview

            16.3.3.2. Product Portfolio

            16.3.3.3. Analyst Commentary 

            16.3.3.4. Key Financials

            16.3.3.5. Recent Developments

            16.3.3.6. Sales Footprint

            16.3.3.7. Strategy Overview

                16.3.3.7.1. Marketing Strategy

                16.3.3.7.2. Product Strategy

                16.3.3.7.3. Channel Strategy

        16.3.4. Novacyt Group

            16.3.4.1. Overview

            16.3.4.2. Product Portfolio

            16.3.4.3. Analyst Commentary 

            16.3.4.4. Key Financials

            16.3.4.5. Recent Developments

            16.3.4.6. Sales Footprint

            16.3.4.7. Strategy Overview

                16.3.4.7.1. Marketing Strategy

                16.3.4.7.2. Product Strategy

                16.3.4.7.3. Channel Strategy

        16.3.5. Aurora Instruments Ltd.

            16.3.5.1. Overview

            16.3.5.2. Product Portfolio

            16.3.5.3. Analyst Commentary 

            16.3.5.4. Key Financials

            16.3.5.5. Recent Developments

            16.3.5.6. Sales Footprint

            16.3.5.7. Strategy Overview

                16.3.5.7.1. Marketing Strategy

                16.3.5.7.2. Product Strategy

                16.3.5.7.3. Channel Strategy

        16.3.6. Glenbio Ltd

            16.3.6.1. Overview

            16.3.6.2. Product Portfolio

            16.3.6.3. Analyst Commentary 

            16.3.6.4. Key Financials

            16.3.6.5. Recent Developments

            16.3.6.6. Sales Footprint

            16.3.6.7. Strategy Overview

                16.3.6.7.1. Marketing Strategy

                16.3.6.7.2. Product Strategy

                16.3.6.7.3. Channel Strategy

        16.3.7. PRIMA Lab SA

            16.3.7.1. Overview

            16.3.7.2. Product Portfolio

            16.3.7.3. Analyst Commentary 

            16.3.7.4. Key Financials

            16.3.7.5. Recent Developments

            16.3.7.6. Sales Footprint

            16.3.7.7. Strategy Overview

                16.3.7.7.1. Marketing Strategy

                16.3.7.7.2. Product Strategy

                16.3.7.7.3. Channel Strategy

        16.3.8. SD Biosensor, INC.

            16.3.8.1. Overview

            16.3.8.2. Product Portfolio

            16.3.8.3. Analyst Commentary 

            16.3.8.4. Key Financials

            16.3.8.5. Recent Developments

            16.3.8.6. Sales Footprint

            16.3.8.7. Strategy Overview

                16.3.8.7.1. Marketing Strategy

                16.3.8.7.2. Product Strategy

                16.3.8.7.3. Channel Strategy

        16.3.9. Gold Standard Diagnostics

            16.3.9.1. Overview

            16.3.9.2. Product Portfolio

            16.3.9.3. Analyst Commentary 

            16.3.9.4. Key Financials

            16.3.9.5. Recent Developments

            16.3.9.6. Sales Footprint

            16.3.9.7. Strategy Overview

                16.3.9.7.1. Marketing Strategy

                16.3.9.7.2. Product Strategy

                16.3.9.7.3. Channel Strategy

        16.3.10. Eurofins Technologies

            16.3.10.1. Overview

            16.3.10.2. Product Portfolio

            16.3.10.3. Analyst Commentary 

            16.3.10.4. Key Financials

            16.3.10.5. Recent Developments

            16.3.10.6. Sales Footprint

            16.3.10.7. Strategy Overview

                16.3.10.7.1. Marketing Strategy

                16.3.10.7.2. Product Strategy

                16.3.10.7.3. Channel Strategy

        16.3.11. myLAB Box

            16.3.11.1. Overview

            16.3.11.2. Product Portfolio

            16.3.11.3. Analyst Commentary 

            16.3.11.4. Key Financials

            16.3.11.5. Recent Developments

            16.3.11.6. Sales Footprint

            16.3.11.7. Strategy Overview

                16.3.11.7.1. Marketing Strategy

                16.3.11.7.2. Product Strategy

                16.3.11.7.3. Channel Strategy

        16.3.12. Biomerieux SA

            16.3.12.1. Overview

            16.3.12.2. Product Portfolio

            16.3.12.3. Analyst Commentary 

            16.3.12.4. Key Financials

            16.3.12.5. Recent Developments

            16.3.12.6. Sales Footprint

            16.3.12.7. Strategy Overview

                16.3.12.7.1. Marketing Strategy

                16.3.12.7.2. Product Strategy

                16.3.12.7.3. Channel Strategy

        16.3.13. Danaher

            16.3.13.1. Overview

            16.3.13.2. Product Portfolio

            16.3.13.3. Analyst Commentary 

            16.3.13.4. Key Financials

            16.3.13.5. Recent Developments

            16.3.13.6. Sales Footprint

            16.3.13.7. Strategy Overview

                16.3.13.7.1. Marketing Strategy

                16.3.13.7.2. Product Strategy

                16.3.13.7.3. Channel Strategy

        16.3.14. F. Hoffmann-La Roche Ltd

            16.3.14.1. Overview

            16.3.14.2. Product Portfolio

            16.3.14.3. Analyst Commentary 

            16.3.14.4. Key Financials

            16.3.14.5. Recent Developments

            16.3.14.6. Sales Footprint

            16.3.14.7. Strategy Overview

                16.3.14.7.1. Marketing Strategy

                16.3.14.7.2. Product Strategy

                16.3.14.7.3. Channel Strategy

        16.3.15. Qiagen NV

            16.3.15.1. Overview

            16.3.15.2. Product Portfolio

            16.3.15.3. Analyst Commentary 

            16.3.15.4. Key Financials

            16.3.15.5. Recent Developments

            16.3.15.6. Sales Footprint

            16.3.15.7. Strategy Overview

                16.3.15.7.1. Marketing Strategy

                16.3.15.7.2. Product Strategy

                16.3.15.7.3. Channel Strategy

        16.3.16. Abbott

            16.3.16.1. Overview

            16.3.16.2. Product Portfolio

            16.3.16.3. Analyst Commentary 

            16.3.16.4. Key Financials

            16.3.16.5. Recent Developments

            16.3.16.6. Sales Footprint

            16.3.16.7. Strategy Overview

                16.3.16.7.1. Marketing Strategy

                16.3.16.7.2. Product Strategy

                16.3.16.7.3. Channel Strategy

        16.3.17. Thermo Fisher Scientific Inc

            16.3.17.1. Overview

            16.3.17.2. Product Portfolio

            16.3.17.3. Analyst Commentary 

            16.3.17.4. Key Financials

            16.3.17.5. Recent Developments

            16.3.17.6. Sales Footprint

            16.3.17.7. Strategy Overview

                16.3.17.7.1. Marketing Strategy

                16.3.17.7.2. Product Strategy

                16.3.17.7.3. Channel Strategy

17. Assumptions and Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Covid-19 testing Market Volume (Million Units) Analysis Forecast 2021-2031, By Test Type

Table 02: Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Sample Type

Table 03: Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Distribution Channel

Table 04: Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Region

Table 06: U.S Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Sample Type

Table 07: U.S Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Distribution Channel

Table 08: Canada Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Sample Type

Table 09: Canada Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Distribution Channel

Table 10: Latin America Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Sample Type

Table 11: Latin America Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Distribution Channel

Table 12: Covid-19 Testing Market Value (US$ Mn) Analysis Forecast 2021-2031, By Test Type

Table 13: Covid-19 Testing Market Volume (Units) Analysis Forecast 2021-2031, By Test Type

Table 14: U.S Covid-19 Testing Market Value (US$ Mn) Analysis Forecast 2021-2031, By Test Type

Table 15: U.S Covid-19 Testing Market Volume (Units) Analysis Forecast 2021-2031, By Test Type

Table 16: Canada Covid-19 Testing Market Value (US$ Mn) Analysis Forecast 2021-2031, By Test Type

Table 17: Canada Covid-19 Testing Market Volume (Units) Analysis Forecast 2021-2031, By Test Type

Table 18: Latin America Covid-19 Testing Market Value (US$ Mn) Analysis Forecast 2021-2031, By Test Type

Table 19: Latin America Covid-19 Testing Market Volume (Units) Analysis Forecast 2021-2031, By Test Type

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Covid-19 Testing Market Value (US$ Mn), Volume (Unit) and Forecast, 2020-2031

Figure 02: Covid-19 Testing Market Incremental $ Opportunity, 2021-2031

Figure 03: Regional Average Pricing Analysis Benchmark USD (Units) By Test Type (2020)

Figure 04: Covid-19 Testing Market Analysis by Test Type –2021 & 2031

Figure 05: Covid-19 Testing Market Y-o-Y Growth Projections by Test Type, 2021 – 2031

Figure 06: Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Test Type

Figure 07: Covid-19 Testing Market Analysis by Sample Type –2021 & 2031

Figure 08: Covid-19 Testing Market Y-o-Y Growth Projections by Sample Type, 2021 – 2031

Figure 09: Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Sample Type

Figure 10: Covid-19 Testing Market Analysis by Distribution Channel –2021 & 2031

Figure 11: Covid-19 Testing Market Y-o-Y Growth Projections by Distribution Channel, 2021 – 2031

Figure 12: Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Distribution Channel

Figure 13: Covid-19 Testing Market Analysis by Region –2021 & 2031

Figure 14: Covid-19 Testing Market Y-o-Y Growth Projections by Region, 2021 – 2031

Figure 15: Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Region

Figure 16: Covid-19 Testing Market Split by Product Type (2021E)

Figure 17: Covid-19 Testing Market Split by Sample Type (2021E)

Figure 18: Covid-19 Testing Market Split by Distribution Channel (2021E)

Figure 19: U.S. Covid-19 Testing Market Value (US$ Mn), Volume (Unit) 2020-2031

Figure 20: U.S Covid-19 Testing Market Attractiveness Analysis by Sample Type, 2021-2031

Figure 21: Covid-19 Testing Market Value Share, by Test Type (2021 E)

Figure 21: U.S Covid-19 Testing Market Attractiveness Analysis by Distribution Channel, 2021-2031

Figure 22: Covid-19 Testing Market Value Share, by Sample Type (2021 E)

Figure 22: U.S Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Test Type

Figure 23: Covid-19 Testing Market Value Share, by Distribution Channel (2021 E)

Figure 23: Covid-19 Testing Market Split by Product Type (2021E)

Figure 24: Covid-19 Testing Market Value Share, by Region (2021 E)

Figure 24: Covid-19 Testing Market Split By Sample Type (2021E)

Figure 25: Covid-19 Testing Market Split By Distribution Channel (2021E)

Figure 26: Canada Covid-19 Testing Market Value (US$ Mn), Volume (Unit) 2020-2031

Figure 27: Canada Covid-19 Testing Market Attractiveness Analysis by Sample Type, 2021-2031

Figure 28: Canada Covid-19 Testing Market Attractiveness Analysis by Distribution Channel, 2021-2031

Figure 29: Canada Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Test Type

Figure 30: Covid-19 Testing Market Split By Product Type (2021E)

Figure 31: Covid-19 Testing Market Split By Sample Type (2021E)

Figure 32: Covid-19 Testing Market Split By Distribution Channel (2021E)

Figure 33: Latin America Covid-19 Testing Market Value (US$ Mn), Volume (Unit) 2020-2031

Figure 34: Latin America Covid-19 Testing Market Attractiveness Analysis by Sample Type, 2021-2031

Figure 35: Latin America Covid-19 Testing Market Attractiveness Analysis by Distribution Channel, 2021-2031

Figure 36: Latin America Covid-19 Testing Market Size (US$ Mn) Analysis Forecast 2021-2031, By Test Type

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Coronavirus Immunoassay Market

Published : June 2022

Healthcare

COVID-19 Saliva Sampling Test Potential Market

Published : June 2022

Healthcare

Covid-19 Vaccine Development Tools Market

Published : May 2022

Healthcare

Covid-19 Diagnostics Market

Published : August 2020

Google translate

Americas COVID-19 Testing Market